Technical guidance
Critical preparedness, readiness and response actions for COVID-19
Country-level coordination, planning, and monitoring
The Unity Studies: Early Investigations Protocols
Risk communication and community engagement
Naming the coronavirus disease (COVID-19)
Surveillance, rapid response teams, and case investigation
Clinical care
Essential resource planning
Virus origin/Reducing animal-human transmission
Humanitarian operations, camps, refugees/migrants in non-camps and other fragile settings
National laboratories
Infection prevention and control / WASH
Guidance for schools, workplaces & institutions
Points of entry / mass gatherings
Health workers
Maintaining Essential Health Services and Systems
Smoking and COVID-19
Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19
Bacille Calmette-Guérin (BCG) vaccination and COVID-19
COVID-19 and the use of angiotensin-converting enzyme inhibitors and receptor blockers
Off-label use of medicines for COVID-19
"Immunity passports" in the context of COVID-19
Advice on the use of point-of-care immunodiagnostic tests for COVID-19
The use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with COVID-19
Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations
